Publicacions en què col·labora amb MONTSERRAT MARTINEZ ALONSO (11)

2021

  1. Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort

    Nutrients, Vol. 13, Núm. 3, pp. 1-15

  2. Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054

2019

  1. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  2. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  3. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study

    Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 1, pp. 128-135

  4. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2017

  1. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer

    Molecular Imaging and Biology, Vol. 18, Núm. 4, pp. 545-556

  2. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia, Vol. 36, Núm. 4, pp. 389-396

  3. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 389-396

2009

  1. Expression of somatostatin receptors in human melanoma cell lines: Effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation

    Journal of International Medical Research, Vol. 37, Núm. 6, pp. 1813-1822